Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03658811 · ClinicalTrials.gov registry record · NA

Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease

A NA study of Dry Eye, sponsored by Toyos Clinic.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT03658811 is a NA study of Dry Eye that has completed, run by Toyos Clinic. The registered enrollment target is 19 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03658811, a NA study of Dry Eye, has completed, sponsored by Toyos Clinic.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Upper eyelid treatment has not been used with previously described methods of treatment of dry eye disease using intense pulsed light therapy because the upper lids disease was typically not as advanced as lower lid and because direct treatment of the upper lid was not felt to be necessary as each light pulse extended over the entire periorbita even when concentrated on the lower lid.

Conditions Studied

Interventions

  • DEVICE intense pulsed light

Study Locations (1)

Tennessee

  • Toyos Clinic - Nashville

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2018-09-01
Est. Completion 2018-10-31
Phase NA

Sponsor

Toyos Clinic

7 total trials

What the Registry Record Tells You About NCT03658811

The ClinicalTrials.gov registry entry for NCT03658811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (80% lower). The listed sponsor is Toyos Clinic, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which intense pulsed light is the first listed.

NCT03658811 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03658811 about?

NCT03658811 is a clinical study titled "Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease". Upper eyelid treatment has not been used with previously described methods of treatment of dry eye disease using intense pulsed light therapy because the upper lids disease was typically not as advanced as lower lid and because direct treatment of the upper lid was not felt to be necessary as each l...

What is the current status of trial NCT03658811?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-09-01. Estimated completion is 2018-10-31.

What conditions does trial NCT03658811 study?

This clinical trial studies the following conditions: Dry Eye.

What interventions are being tested in trial NCT03658811?

The interventions under investigation include: intense pulsed light (DEVICE).

Who is sponsoring clinical trial NCT03658811?

This trial is sponsored by Toyos Clinic, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03658811 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dry Eye

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.